Amanda MS, Boman GI, Marcus CM, Carrie H-L, William JM
For non-diabetic patients exploring GLP-1 therapy, understanding both your biomarkers (glucose, insulin, lipids) and your genetic context can support a more confident, evidence-informed discussion with your provider about whether this treatment approach is appropriate for you and what outcomes to expect
This long clinical history gives patients and providers added confidence in its safety and efficacy
Patients are encouraged to discuss the risks, benefits, and appropriateness of any medications, including compounded products, with their healthcare provider before use
It is a logical assumption that if sperm quality is improved that more babies will follow
Second, the oral formulation provides an alternative to injectable GLP-1 receptor agonists, potentially improving adherence and enabling earlier initiation of cardiovascular risk-reducing therapy in routine practice